Correlation of PET-CT Studies With Serum Protein Analysis
NCT00547742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2010-07-20
Summary
To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.
Conditions
- Carcinomas (Including Squamous Cell and Adenocarcinoma)
Interventions
- PROCEDURE
-
PET/CT Scan
- PROCEDURE
-
phlebotomy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Dr Andrew Quon · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-06-30
Countries
- United States
Study Locations
More Related Trials
-
Integrin αvβ6-targeted PET in Malignant Tumors
NCT05835570 ·Status: RECRUITING
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
NCT02550847 ·Status: UNKNOWN
-
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
NCT00828126 ·Status: COMPLETED
-
[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity
NCT05806333 ·Status: UNKNOWN ·Phase: NA
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
PET/MR Characterization of Renal Cell Carcinomas
NCT04271254 ·Status: TERMINATED ·Phase: NA
-
PET MRI as a Staging Tool for Head and Neck Cancer
NCT04750434 ·Status: COMPLETED
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
NCT06690216 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
NCT03077334 ·Status: COMPLETED
-
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
NCT02817945 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT00335751 ·Status: COMPLETED ·Phase: NA
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
NCT06344832 ·Status: NOT_YET_RECRUITING
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
NCT05513027 ·Status: TERMINATED ·Phase: NA
-
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
NCT04457232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
68Ga-FAPI PET/CT in Malignant Tumors
NCT05034146 ·Status: RECRUITING ·Phase: NA
-
PET Scan in Treating Patients With Metastatic Prostate Cancer
NCT00002981 ·Status: COMPLETED ·Phase: NA
-
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
NCT00862680 ·Status: COMPLETED
-
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma
NCT05275985 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
NCT01888692 ·Status: TERMINATED